We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $999B
1-Year Est. Return 46.22%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+29.22%
1 Year Est. Return
+46.22%
3 Year Est. Return
+150.45%
5 Year Est. Return
+185.95%
10 Year Est. Return
+871.56%
AUM
$999B
AUM Growth
+$134B
Cap. Flow
-$3.54B
Cap. Flow %
-0.35%
Top 10 Hldgs %
32.24%
Holding
3,356
New
224
Increased
2,237
Reduced
645
Closed
116

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$12.1B
2
AAPL icon
Apple
AAPL
+$11.6B
3
AMZN icon
Amazon
AMZN
+$3.54B
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$3.07B
5
KEYS icon
Keysight
KEYS
+$1.82B

Sector Composition

Rank Sector Weight
1 Technology 37.73%
2 Healthcare 11.3%
3 Financials 10.32%
4 Communication Services 9.66%
5 Industrials 9.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSI icon
351
Motorola Solutions
MSI
$75.6B
$359M 0.04%
864,557
-54,719
-6% -$22.9M
EBAY icon
352
eBay
EBAY
$48B
$355M 0.04%
3,178,621
-355,311
-10% -$37.9M
ALKS icon
353
Alkermes
ALKS
$6.85B
$353M 0.04%
6,737,328
+2,072,752
+44% +$80.9M
PFE icon
354
Pfizer
PFE
$163B
$350M 0.04%
14,517,091
-1,157,814
-7% -$30.3M
CI icon
355
Cigna
CI
$71.9B
$349M 0.03%
1,265,062
-1,307,781
-51% -$369M
MO icon
356
Altria Group
MO
$115B
$348M 0.03%
4,838,426
+195,545
+4% +$13.6M
RYN icon
357
Rayonier
RYN
$5.62B
$346M 0.03%
16,259,447
+26,982
+0.2% +$565K
ALNY icon
358
Alnylam Pharmaceuticals
ALNY
$34.2B
$346M 0.03%
1,149,201
-283,547
-20% -$85.5M
AXS icon
359
AXIS Capital
AXS
$6.89B
$343M 0.03%
3,194,801
+1,635,503
+105% +$164M
CRL icon
360
Charles River Laboratories
CRL
$14B
$341M 0.03%
1,505,370
+380,227
+34% +$67.7M
TTE icon
361
TotalEnergies
TTE
$201B
$339M 0.03%
4,355,928
+100,246
+2% +$8.87M
BELFB
362
Bel Fuse Inc Class B
BELFB
$3.65B
$338M 0.03%
1,015,705
+242,230
+31% +$65.4M
AGX icon
363
Argan
AGX
$5.11B
$335M 0.03%
420,104
+328,238
+357% +$218M
BURL icon
364
Burlington
BURL
$16B
$333M 0.03%
1,050,437
+196,803
+23% +$63.5M
TMSL icon
365
T. Rowe Price Small-Mid Cap ETF
TMSL
$2.97B
$332M 0.03%
7,570,406
+544,219
+8% +$22.2M
GFS icon
366
GlobalFoundries
GFS
$27.3B
$328M 0.03%
3,985,630
+3,921,799
+6,144% +$274M
MOG.A icon
367
Moog Inc Class A
MOG.A
$12.3B
$328M 0.03%
774,034
+251,044
+48% +$85.7M
UBER icon
368
Uber
UBER
$142B
$327M 0.03%
4,529,967
+547,983
+14% +$40.2M
BAH icon
369
Booz Allen Hamilton
BAH
$8.77B
$326M 0.03%
5,371,943
-1,260,981
-19% -$96.3M
EGP icon
370
EastGroup Properties
EGP
$10.8B
$325M 0.03%
1,606,755
-19,807
-1% -$3.97M
SLM icon
371
SLM Corp
SLM
$4.45B
$325M 0.03%
12,522,958
+4,086,231
+48% +$92M
HR icon
372
Healthcare Realty
HR
$6.19B
$324M 0.03%
16,087,364
+86,131
+0.5% +$1.67M
VSAT icon
373
Viasat
VSAT
$10.1B
$324M 0.03%
3,609,904
+424,278
+13% +$28.1M
JCI icon
374
Johnson Controls International
JCI
$91B
$324M 0.03%
2,218,717
+114,843
+5% +$16.2M
EXE
375
Expand Energy Corp
EXE
$20.1B
$324M 0.03%
3,554,701
-164,334
-4% -$15.6M

Similar funds

T. Rowe Price Associates's Q2 2026 Portfolio in Review

As of Q2 2026, T. Rowe Price Associates held 3,356 positions worth $999B, up 16% from $865B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

T. Rowe Price Associates's Q2 2026 filing shows 224 new, 2,237 increased, 645 reduced and 116 closed positions. Its largest new stake was SpaceX: 10,709,016 shares worth $1.83B. The largest sale was Microsoft, an estimated $12.1B.

By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 34% a quarter earlier, followed by Healthcare and Financials.

  • T. Rowe Price Associates's largest Q2 2026 buy was SpaceX: 10,709,016 shares worth $1.83B.
  • T. Rowe Price Associates added most to Alphabet (Google) Class A in Q2 2026, an estimated $7.49B increase.
  • T. Rowe Price Associates's biggest Q2 2026 reduction was Microsoft, cutting an estimated $12.1B.
  • T. Rowe Price Associates fully exited Sibanye-Stillwater in Q2 2026, selling an estimated $40.4M.
  • T. Rowe Price Associates's ten largest holdings make up 32% of its $999B portfolio in Q2 2026.
  • T. Rowe Price Associates opened 224 new positions and closed 116 in Q2 2026.
  • T. Rowe Price Associates's portfolio value rose 16% quarter-over-quarter to $999B.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.